Dr. David Samadi, leading prostate cancer urologist, highlights the importance of the PSA screening test and digital rectal exam (DRE) for prostate cancer. Many patients are symptom-free when diagnosed with prostate cancer. One of Dr. Samadi's patients and his wife speak about the life-saving benefits of the PSA test.
PSA screening should be done at age 40 as a baseline, and if normal repeated annually after age 45. The importance of the PSA is in monitoring the velocity or trend, not just in the value of one test.
Dr. Samadi acknowledges that not all prostate cancers are deadly, but says that the art of medicine, surgeon expertise, and the role of centers of excellence all ensure patient survival in evaluating prostate cancer.